Floriva-F (25 mcg+50 mcg)/puff (Inhaler)

Indications

• Regular treatment of asthma
• Combination product for long-acting β2-agonist and inhaled corticosteroid
• Control of asthma in patients not adequately controlled with inhaled corticosteroids
• Control of asthma in patients already adequately controlled on both inhaled corticosteroid and long-acting β2-agonist

Pharmacology

• Selective, long-acting beta-2 agonist
• Corticosteroid with mainly glucocorticoid activity
• Salmeterol protects against symptoms
• Fluticasone Propionate improves lung function
• Prevention of exacerbations of asthma
• Convenient regime for patients on concurrent β-agonist and inhaled corticosteroid therapy

Dosage

• Adult dosage
• Adolescent dosage
• Children dosage
• Starting dosages
• Maximum recommended dosage
• Dosage for COPD
• Instructions for inhaler use
• Instructions for cleaning inhaler

Administration

• Proper use of inhaler
• Steps for using inhaler
• Technique for using inhaler
• Instructions for cleaning inhaler

Interaction

• Avoidance of non-selective and selective β-blockers in asthmatic patients
• Potential interaction with strong CYP3A4 inhibitors

Contraindications

• Hypersensitivity to salmeterol xinafoate or fluticasone propionate
• Contraindicated in primary treatment of status asthmaticus or other acute episodes of asthma

Side Effects

• Adverse reactions associated with Salmeterol
• Adverse reactions associated with Fluticasone Propionate
• Adverse reactions following concurrent administration
• Relief measures for adverse events

Pregnancy & Lactation

• Consideration of administration during pregnancy and lactation
• Reproductive toxicity studies in animals
• Concentration in human breast milk

Precautions & Warnings

• Initiation in asthma patients
• Use of relief medication
• Asthma-related adverse events
• Paradoxical Bronchospasm
• Increased reporting of pneumonia in COPD patients
• Systemic effects of corticosteroids

Use in Special Populations

• Effects on growth velocity in paediatric patients

Overdose Effects

• Signs and symptoms of Salmeterol overdose
• Signs and symptoms of Fluticasone Propionate overdose
• Treatment for overdose

Therapeutic Class

• Long-acting selective β-adrenoceptor stimulants
• Respiratory corticosteroids

Storage Conditions

• Pressurised canister
• Avoid puncture, breakage, or incineration
• Avoid storage in direct sunlight or heat
• Store below 30°C
• Keep away from eyes
• Keep away from children

Related Brands

• Floriva-F (25 mcg+125 mcg)/puff (Inhaler) - opsonin-pharma-ltd
• Floriva-F 50 mcg+250 mcg (Inhalation Capsule) - opsonin-pharma-ltd
• Aroflo 50 mcg+250 mcg (Inhalation Capsule) - aristopharma-ltd
• Saltica 50 mcg+250 mcg (Inhalation Capsule) - renata-limited
• Saltica 50 mcg+500 mcg (Inhalation Capsule) - renata-limited